NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01734928,"Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma",https://clinicaltrials.gov/study/NCT01734928,OPTIMISMM,COMPLETED,"The purpose of this study is to compare the efficacy of the combination of pomalidomide, bortezomib and low dose dexamethasone to the combination of bortezomib and low dose dexamethasone in participants with relapsed/refractory multiple myeloma. This study will also assess how safe the combination of pomalidomide, bortezomib and low dose dexamethasone is compared to the combination of bortezomib and low dose dexamethasone.",YES,Multiple Myeloma,DRUG: Pomalidomide|DRUG: Bortezomib|DRUG: Dexamethasone,"Progression Free Survival by Independent Response Adjudication Committee (IRAC), Progression free survival (PFS) will be calculated as the time between the randomization and progressive disease (PD) or death.

Progressive Disease is defined as an Increase of ≥ 25% from nadir in:

* Serum M-component and/or (the absolute increase must be ≥ 0.5 g/dL)g
* Urine M-component and/or (the absolute increase must be ≥ 200 mg/24 hours)
* In patients without measurable serum and urine M-protein levels the difference between involved and uninvolved FLC levels, the absolute increase must be \> 100 mg/dL.
* Bone marrow plasma cell percentage, the absolute % must be ≥ 10%h
* Definite development of new bone lesions or soft tissue plasmacytomas increase in the size of existing bone lesions or soft tissue plasmacytomas. -Development of hypercalcemia (corrected serum calcium \> 11.5 mg/dL or 2.65 mmol/L) that can be attributed solely to the plasma cell proliferative disorder., From randomization to progressive disease or death during the IRAC assessment period, up to approximately 42 months","Overall Survival (OS), Overall survival (OS) is calculated as the time from randomization to death from any cause., From randomization to date of death, up to approximately 65 months|Overall Response Rate by Independent Response Adjudication Committee (IRAC), The ORR together with the relative proportions in each response category (ie, stringent CR \[sCR\], CR, very good PR \[VGPR\], PR, SD, and PD) by treatment using the IMWG criteria will be examined.

Complete Response: Negative immunofixation on the serum and urine and disappearance of any soft tissue plasmacytomas and ≤ 5% plasma cells in bone marrow

SCR: CR+ Normal FLC ratio and Absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence

VGPR: Serum and urine M-protein detectable by immunofixation but not on electrophoresis or 90% or greater reduction in serum M-protein plus urine Mprotein level \< 100 mg per 24 hours

PR: ≥ 50% reduction of serum M-Protein and reduction in 24-hour urinary M-protein by ≥ 90% or to \< 200 mg per 24 hours

Progressive Disease: Please refer to Primary outcome measure for definition

SD: Not meeting criteria for CR, VGPR, PR, or progressive disease, From randomization to progressive disease or death during the IRAC assessment period, up to approximately 42 months|Duration of Response by Independent Response Adjudication Committee (IRAC), Duration of myeloma response is defined as the duration from the time when the IMWG response criteria are first met for sCR or CR or VGPR or PR until the first date the response criteria are met for PD or until the subject died from any cause, whichever occurs first.

Complete Response: Negative immunofixation on the serum and urine and disappearance of any soft tissue plasmacytomas and ≤ 5% plasma cells in bone marrow

SCR: CR+ Normal FLC ratio and Absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence

VGPR: Serum and urine M-protein detectable by immunofixation but not on electrophoresis or 90% or greater reduction in serum M-protein plus urine Mprotein level \< 100 mg per 24 hours

PR: ≥ 50% reduction of serum M-Protein and reduction in 24-hour urinary M-protein by ≥ 90% or to \< 200 mg per 24 hours

Progressive Disease: Please refer to Primary outcome measure for definition

SD: Not meeting criteria for CR, VGPR, PR, or progressive disease, From randomization to progressive disease or death during the IRAC assessment period, up to approximately 42 months|Number of Participants With Grade 3-4 Treatment Emergent Adverse Events (TEAE), Treatment-emergent adverse events (TEAEs) are defined as any AE occurring or worsening on or after the first dose date of the study treatment and within 28 days after the last dose date., From first dose to 28 days after the last dose (up to approximately 44 months|Number of Participants With Grade 5 Treatment Emergent Adverse Events (TEAE), Treatment-emergent adverse events (TEAEs) are defined as any AE occurring or worsening on or after the first dose date of the study treatment and within 28 days after the last dose date., From first dose to 28 days after the last dose (up to approximately 44 months",,Celgene,,ALL,"ADULT, OLDER_ADULT",PHASE3,559,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CC-4047-MM-007,2013-01-07,2022-05-09,2022-05-13,2012-11-28,2023-06-06,2023-06-06,"Southern Cancer Center, Mobile, Alabama, 36608, United States|Arizona Oncology, Tucson, Arizona, 85710, United States|University of Arizona Cancer Center, Tucson, Arizona, 85724, United States|Alta Bates Comprehensive Cancer Center, Berkeley, California, 94704, United States|University of California San Francisco Fresno Campus, Fresno, California, 93701, United States|Marin Oncology Associates, Greenbrae, California, 94904-2007, United States|Moore UCSD Cancer Center, La Jolla, California, 92083, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, 95403, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Cancer Center of Central Connecticut, Southington, Connecticut, 06489, United States|Local Institution - 153, Southington, Connecticut, 06489, United States|George Washington Medical Center, Washington, District of Columbia, 20037, United States|Lynn Cancer Institute, Boca Raton, Florida, 33486, United States|University Cancer Institute, Boynton Beach, Florida, 33426, United States|Broward Oncology Associates PA, Fort Lauderdale, Florida, 33308, United States|Broward Oncology Assoc., Fort Lauderdale, Florida, 33316, United States|University of Florida, Gainesville, Florida, 32610, United States|Alves Domenech Oncology and Hematology Clinic, Hollywood, Florida, 33021, United States|Palm Beach Cancer Institute, LLC, West Palm Beach, Florida, 33401, United States|Local Institution - 135, Marietta, Georgia, 30060, United States|Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute, Marietta, Georgia, 30060, United States|University of Chicago, Chicago, Illinois, 60637-1470, United States|Investigative Clinical Research of Indiana, LLC, Indianapolis, Indiana, 46254, United States|University of Iowa, Iowa City, Iowa, 52242, United States|Western Kentucky Hematology and Oncology Group, PSC, Paducah, Kentucky, 42003, United States|Tulane University Medical Center, New Orleans, Louisiana, 70112, United States|Cancer Care of Maine, Bangor, Maine, 04401, United States|Local Institution - 132, Bangor, Maine, 04401, United States|St. Agnes - Medical Center, Baltimore, Maryland, 21229-5299, United States|Center for Cancer and Blood Disorders, Bethesda, Maryland, 20817, United States|Local Institution - 125, Bethesda, Maryland, 20817, United States|Medstar Health Research Institute, Hyattsville, Maryland, 20782, United States|Local Institution - 299, Boston, Massachusetts, 02114, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Local Institution - 100, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Local Institution - 298, Boston, Massachusetts, 02215, United States|Henry Ford Medical Center - New Center One, Detroit, Michigan, 48202-268, United States|Local Institution - 178, Detroit, Michigan, 48202-268, United States|Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan, 49546, United States|Detroit Clinical Research Center, Lansing, Michigan, 48912, United States|Beaumont Cancer Center, Royal Oak, Michigan, 48073, United States|Essentia Health Duluth CCOP, Duluth, Minnesota, 55805, United States|Metro MN CCOP, Saint Louis Park, Minnesota, 55416, United States|Columbia Comprehensive, Jefferson City, Missouri, 65203, United States|Kansas City VA Medical Center University of Kansas Medical Center, Kansas City, Missouri, 64128, United States|St John's Mercy Medical Center, Saint Louis, Missouri, 63141, United States|St. John's Clinic Cancerand Hematology - Springfield, Springfield, Missouri, 65804, United States|Billings Clinic, Billings, Montana, 59102, United States|Southeast Nebraska Cancer Center, Lincoln, Nebraska, 68510, United States|CarePoint Health Research Institute, Jersey City, New Jersey, 07306, United States|Hematology-Oncology Associates of NNJ, P, Morristown, New Jersey, 07960, United States|Somerset Hematology-Oncology Associates, Somerville, New Jersey, 08876, United States|Local Institution - 186, Bronx, New York, 10467, United States|Montefiore Medical Center, Bronx, New York, 10467, United States|Mount Sinai Hospital, New York, New York, 10029, United States|Stony Brook University, Stony Brook, New York, 11794-7300, United States|New York Medical College, Valhalla, New York, 10595, United States|Eastern Institute of Medical Sciences, Greenville, North Carolina, 27834, United States|Boice-Willis Clinic P.A., Rocky Mount, North Carolina, 27804, United States|Gabrail Cancer Center Research, Canton, Ohio, 44718, United States|Local Institution - 111, Canton, Ohio, 44718, United States|MetroHealth Medical Systems, Cleveland, Ohio, 44109, United States|Mid Ohio Oncology Hematology Inc, Columbus, Ohio, 43219, United States|University of Toledo Medical Center, Toledo, Ohio, 43614, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Med Univ of South Carolina, Charleston, South Carolina, 29425, United States|Spartanburg Regional Healthcare System - Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, 29303, United States|Avera Research Institute, Sioux Falls, South Dakota, 57105, United States|Local Institution - 167, Watertown, South Dakota, 57201, United States|Prairie Lakes Health Care System, Watertown, South Dakota, 57201, United States|University of Tennessee Medical Center - Cancer Institute, Knoxville, Tennessee, 37885, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232-5505, United States|Local Institution - 114, Dallas, Texas, 75390, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|Brooke Army Medical Center Francis Street Medical Center, Fort Sam Houston, Texas, 78235-8200, United States|Local Institution - 103, Fort Sam Houston, Texas, 78235-8200, United States|Local Institution - 130, Houston, Texas, 77090, United States|Northwest Cancer Center, Houston, Texas, 77090, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, 79410, United States|Utah Cancer Specialist, Salt Lake City, Utah, 84106, United States|Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah, 84112, United States|Swedish Cancer Inst, Seattle, Washington, 98104, United States|Medical Oncology Associates, Spokane, Washington, 99208, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, 98801, United States|Local Institution - 139, Morgantown, West Virginia, 25606, United States|West Virginia University CTRU, Morgantown, West Virginia, 25606, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Local Institution - 136, Milwaukee, Wisconsin, 53226, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Hospital St. Polten, St. Pölten, 3100, Austria|Local Institution - 523, St. Pölten, 3100, Austria|Local Institution - 480, Vienna, 1090, Austria|Medical University of Vienna, Vienna, 1090, Austria|Local Institution - 481, Vienna, 1160, Austria|Wilhelminenspital-Center for Hematology and Oncology, Vienna, 1160, Austria|Local Institution - 308, Oshawa, Ontario, L1G 2B9, Canada|RSM Durham Regional Cancer Center - Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada|CSSS Champlain Charles LeMoyne, Greenfield Park, Quebec, J4V 2H1, Canada|Local Institution - 301, Greenfield Park, Quebec, J4V 2H1, Canada|Centre De Sante Et De Services Sociaux De Rimouski-Neigette, Rimouski, Quebec, G5L5T1, Canada|Centre Hospitalier Universitaire de Sherbrooke-Hospital Fleurimont, Sherbrooke, Quebec, J1H5N4, Canada|Local Institution - 307, Sherbrooke, Quebec, J1H5N4, Canada|Local Institution - 304, Halifax, B3H 2Y9, Canada|Queen Elizabeth II Health Sciences Centre, Halifax, B3H 2Y9, Canada|Aarhus University Hospital, Aarhus, 8000, Denmark|Local Institution - 447, Aarhus, 8000, Denmark|Copenhagen University Hospital Rigshosptalet, Copenhagen, 2100, Denmark|Local Institution - 506, Copenhagen, 2100, Denmark|Local Institution - 400, Odense, DK-5000, Denmark|Odense University Hospital, Odense, DK-5000, Denmark|Local Institution - 499, Vejle, 7100, Denmark|Vejle Hospital, Vejle, 7100, Denmark|Helsinki University Central Hospital, Helsinki, 290, Finland|Local Institution - 455, Helsinki, 290, Finland|Hyvinkaa Hospital, Hyvinkaa, 05850, Finland|Local Institution - 510, Hyvinkaa, 05850, Finland|Centre Hospitalier de la cote basque, Bayonne, 64109, France|Local Institution - 469, Bayonne, 64109, France|Centre Hospitalier William Morey, Chalon sur Saone, 71100, France|Local Institution - 498, Chalon sur Saone, 71100, France|CHU Hotel, Grenoble Cedex 09, 38043, France|Local Institution - 483, Grenoble Cedex 09, 38043, France|GH Institut Catholique St Vincent, Lille, 59000, France|CHRU de Lille-Hopital Claude Huriez, Lille, 59037, France|Local Institution - 476, Lille, 59037, France|CHRU Hotel Dieu, Nantes, 44035, France|Local Institution - 486, Nantes, 44035, France|Groupement Hospitalier Universitaire Est - Hopital Saint-Antoine, Paris, 75012, France|Centre Hospitalier Lyon Sud, Pierre-Bénite Cedex, 69495, France|Local Institution - 497, Pierre-Bénite Cedex, 69495, France|CHU La Miletrie, Poitiers Cedex, 86021, France|Local Institution - 516, Poitiers Cedex, 86021, France|CHRU Rennes, Rennes, 35033, France|Local Institution - 504, Rennes, 35033, France|Institut Universitaire du Cancer de Toulouse (IUCT) - Oncopole, Toulouse Cedex, 31052, France|CHRU Hopital Bretonneau, Tours cedex, 37044, France|Local Institution - 468, Tours cedex, 37044, France|ChariteUniversitatsmedizinCampus Benjamin Franklin, Berlin, D-13353, Germany|Local Institution - 442, Berlin, D-13353, Germany|Local Institution - 417, Dresden, 01307, Germany|Universitaetsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Local Institution - 475, Essen, 45147, Germany|Universitaetsklinikum EssenInnere Klinik und Poliklinik, Essen, 45147, Germany|Local Institution - 496, Freiburg, 79106, Germany|Universitatsklinikum Freiburg, Freiburg, 79106, Germany|Local Institution - 430, Heidelberg, 69120, Germany|University of Heidelberg, Heidelberg, 69120, Germany|Local Institution - 410, Tuebingen, 72076, Germany|UKT Universitaetsklinikum Tuebingen, Tuebingen, 72076, Germany|General Hospital of Athens Evangelismos, Athens, 10676, Greece|Local Institution - 484, Athens, 10676, Greece|Local Institution - 422, Athens, 11528, Greece|University of Athens Medical school - Regional General Hospital, Athens, 11528, Greece|Local Institution - 487, Mezourlo, 41110, Greece|University General Hospital of Larissa, Mezourlo, 41110, Greece|George Papanikolaou General Hospital of Thessaloniki, Thessloniki, 57010, Greece|Local Institution - 465, Thessloniki, 57010, Greece|Local Institution - 462, Dublin, Dublin 7, Ireland|Mater Misericordiae University Hospital, Dublin, Dublin 7, Ireland|Local Institution - 431, Dublin, Dublin 8, Ireland|St James Hospital, Dublin, Dublin 8, Ireland|Local Institution - 413, Galway, ST46QG, Ireland|University College Hospital Galway, Galway, ST46QG, Ireland|Rambam Health Care Campus, Haifa, 31096, Israel|Hadassah Medical Center, Jerusalem, 91120, Israel|Local Institution - 457, Jerusalem, 91120, Israel|Local Institution - 433, Kfar-Saba, 44281, Israel|Meir Medical Center, Kfar-Saba, 44281, Israel|Chaim Sheba Medical Center, Ramat Gan, 52621, Israel|Tel Aviv Sourasky Medical Center Department of Hematology, Tel Aviv, 64239, Israel|Local Institution - 449, Bergamo, 24127, Italy|USC Ematologia, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, 24127, Italy|Local Institution - 456, Bologna, 40138, Italy|Policlinico S. Orsola - Malpighi, Bologna, 40138, Italy|Local Institution - 415, Catania, 95124, Italy|Ospedale Ferrarotto, Catania, 95124, Italy|Local Institution - 403, Modena, 41100, Italy|University of Modena, Modena, 41100, Italy|IRCCS Policlinico San Matteo, Pavia, 27100, Italy|Local Institution - 451, Pavia, 27100, Italy|Azienda Unita Sanitaria Locale (Ausl) Pescara - Presidio Ospedaliero Di Pescara, Pescara, 65124, Italy|Local Institution - 441, Pescara, 65124, Italy|Azienda Ospedaliera di Reggio Emilia - Arcispedale Santa Maria Nuova, Reggio Emilia, 42100, Italy|Local Institution - 414, Reggio Emilia, 42100, Italy|La Sapienza, University of Rome, Rome, 00161, Italy|Local Institution - 460, Rome, 00161, Italy|A.O.U.S. Giovanni e Ruggi d'Aragona UOC UTIC, Salerno, 84131, Italy|Local Institution - 459, Salerno, 84131, Italy|IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013, Italy|Local Institution - 453, San Giovanni Rotondo, 71013, Italy|Azienda Ospedaliera S Maria di Terni, Terni, 05100, Italy|Local Institution - 402, Terni, 05100, Italy|Azienda Ospedaliera San Giovanni Battista, Torino, 10126, Italy|Local Institution - 401, Torino, 10126, Italy|Hitachi General Hospital, Hitachi, Ibaraki, 317-0077, Japan|Local Institution - 620, Hitachi, Ibaraki, 317-0077, Japan|Kameda Medical Center, Kamogawa, 296-8602, Japan|Local Institution - 625, Kamogawa, 296-8602, Japan|Local Institution - 626, Okayama, 701-1192, Japan|Okayama Medical Center, Okayama, 701-1192, Japan|Japan Red Cross Medical Center, Shibuya-ku, 150-8935, Japan|Local Institution - 623, Shibuya-ku, 150-8935, Japan|Local Institution - 622, Tachikawa, 190-0014, Japan|National Hospital Organization Disaster Medical Center, Tachikawa, 190-0014, Japan|Local Institution - 514, Groningen, 9713 GZ, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9713 GZ, Netherlands|Medisch Centrum Leeuwarden, Leeuwarden, 8934 AD, Netherlands|Erasmus Medical Center, Rotterdam, 3015 CN, Netherlands|Local Institution - 494, Rotterdam, 3015 CN, Netherlands|Local Institution - 412, Oslo, 0372, Norway|Oslo universitetssykehus, Rikshospitalet, Oslo, 0372, Norway|St Olavs Hospital, Trondheim, 7006, Norway|Local Institution - 411, Brzozow, 36-200, Poland|Szpital Specjalistyczny w Brzozowie, Brzozow, 36-200, Poland|Szpital Uniwersytecki nr 2 im dr. Jana Biziela, Bydgoszcz, 85-168, Poland|Local Institution - 407, Chorzow, 41-500, Poland|Zespol Szpitali Miejskich, Chorzow, 41-500, Poland|Klinika Hematologii Akademii Medycznej w Gdansku, Gdansk, 80-952, Poland|Local Institution - 463, Gdansk, 80-952, Poland|Local Institution - 440, Krakow, 31-501, Poland|Oddzial Kliniczny Kliniki Hematologii, Krakow, 31-501, Poland|Kopernik Memorial Hospital, Lodz, 93-510, Poland|Local Institution - 418, Lodz, 93-510, Poland|Klinika Hematoonkologii i Transplantacji Szpiku, Lublin, 20-081, Poland|Local Institution - 439, Lublin, 20-081, Poland|Local Institution - 437, Poznan, 60-569, Poland|Oddzial Hematologii i Chorob Rozrostowych Ukladu Krwiotworczego, Poznan, 60-569, Poland|Centrum Onkologii-Instytut im.Marii Sklodowskiej-Curie, Warszawa, 02-781, Poland|Local Institution - 448, Warszawa, 02-781, Poland|Hospital de Braga, Braga, 4710-243, Portugal|Local Institution - 450, Braga, 4710-243, Portugal|Instituto Portugues de Oncologia de Lisboa, Francisco Gentil, Lisboa, 1099-023, Portugal|Local Institution - 454, Lisboa, 1099-023, Portugal|Hospital de Santa Maria, Lisboa, 1649-035, Portugal|Local Institution - 466, Lisboa, 1649-035, Portugal|Fundacao Champalimaud, Lisbon, 1400-038, Portugal|Local Institution - 473, Lisbon, 1400-038, Portugal|Local Institution - 464, Porto, 0, Portugal|Instituto Portugues de Oncologia do Porto, Francisco Gentil, Porto, 4200-072, Portugal|Local Institution - 425, Porto, 4200-072, Portugal|Hospital de Santo Antonio- Porto, Porto, Portugal|Ad-Vance Medical Research, LLC, Ponce, 00717, Puerto Rico|City Clinical Hospital 52, Moscow, 123182, Russian Federation|Local Institution - 521, Moscow, 123182, Russian Federation|Local Institution - 517, Moscow, 125284, Russian Federation|Moscow State Healthcare Institution City clinical hospital n.a. S.P.Botkin, Moscow, 125284, Russian Federation|Local Institution - 520, Nizhny Novgorod, 603126, Russian Federation|State Budgetary Healthcare Institution of Nizhniy Novgorod Region, Nizhny Novgorod, 603126, Russian Federation|Russian Research Institute of Hematology and Transfusiology of the Federal Biomedical Agency, Saint Petersburg, 191024, Russian Federation|Hospital Universitari Germans Trias i Pujol Can Ruti, Badalona (Barcelona), 08916, Spain|Local Institution - 423, Badalona (Barcelona), 08916, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Local Institution - 424, Barcelona, 08036, Spain|Hospital de Basurto-Osakidetza, Bilbao, 48013, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Local Institution - 452, Madrid, 28041, Spain|Hospital Morales Meseguer, Murcia, 30008, Spain|Local Institution - 502, Murcia, 30008, Spain|Complejo Hospitalario De Orense, Orense, 32005, Spain|Local Institution - 526, Orense, 32005, Spain|Clinica Universidad de Navarra, Pamplona, 31008, Spain|Local Institution - 434, Pamplona, 31008, Spain|Complejo Hospitalario Nuestra Senora de Valme, Sevilla, 41014, Spain|Local Institution - 492, Sevilla, 41014, Spain|Hospital Universitario y Politecnico La Fe, Valencia, 46026, Spain|Falu lasarett, Falun, 79182, Sweden|Local Institution - 426, Falun, 79182, Sweden|Local Institution - 478, Gothenburg, 60 Gothenburg, Sweden|Sahlgrenska University Hospital, Gothenburg, 60 Gothenburg, Sweden|Local Institution - 429, Luleå, SE-971 80, Sweden|Sunderby Sjukhus, Luleå, SE-971 80, Sweden|Karolinska University, Stockholm, 14186, Sweden|Local Institution - 471, Stockholm, 14186, Sweden|Sundsvalls sjukhus- Medicinkliniken, Sundsvall, S-85643, Sweden|Ankara University Medical Faculty Cebeci Hospital, Ankara, 06590, Turkey|Local Institution - 428, Ankara, 06590, Turkey|Gazi Universitesi Tip Fakultesi Hastanesi, Ankara, 6500, Turkey|Local Institution - 409, Ankara, 6500, Turkey|Ankara Universitesi Tip Fakultesi, Ankara, Dikimevi Cebeci, Turkey|Local Institution - 408, Ankara, Dikimevi Cebeci, Turkey|Local Institution - 488, Antalya, 07050, Turkey|Medstar Antalya Hospital, Antalya, 07050, Turkey|Eskisehir Osmangazi University, Eskisehir, 26480, Turkey|Local Institution - 420, Eskisehir, 26480, Turkey|Local Institution - 421, Gaziantep, 0, Turkey|Gaziantep University, Gaziantep, Turkey|Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul, 34098, Turkey|Local Institution - 445, Istanbul, 34098, Turkey|Istanbul University Faculty of Medicine, Istanbul, 34390, Turkey|Local Institution - 474, Istanbul, 34390, Turkey|Ege University Medical School, Izmir, 35100, Turkey|Local Institution - 419, Izmir, 35100, Turkey|Karadeniz Teknik Universitesi Tip Fakultesi Farabi Hastanesi, Trabzon, 61080, Turkey|Local Institution - 404, Trabzon, 61080, Turkey|The Royal Bournemouth Hospital, Bournemouth, BH7 7DW, United Kingdom|Kent and Canterbury Hospital, Canterbury Kent, CT1 3NG, United Kingdom|Local Institution - 479, Canterbury Kent, CT1 3NG, United Kingdom|Local Institution - 406, Edinburgh Scotland, EH4 2XU, United Kingdom|Western General Hospital, Edinburgh Scotland, EH4 2XU, United Kingdom|Local Institution - 490, London, NW1 2PG, United Kingdom|University College London Hospitals, London, NW1 2PG, United Kingdom|Kings College Hospital, London, SE5 9RS, United Kingdom|Local Institution - 461, London, SE5 9RS, United Kingdom|Local Institution - 512, Oxford, OX3 7DQ, United Kingdom|University of Oxford, Oxford, OX3 7DQ, United Kingdom|Derriford Hospital Plymouth Oncology Centre Clinical Trials Unit, Plymouth, PL6 8DH, United Kingdom|Local Institution - 515, Plymouth, PL6 8DH, United Kingdom|Local Institution - 500, Sheffield, S10 2JF, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire Hospital, Sheffield, S10 2JF, United Kingdom|Local Institution - 493, Southampton, SO16 6YD, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|University Hospital of North Staffordshire Nhs Trust - City General Hospital, Stoke-On-Trent, ST4 6QG, United Kingdom|Local Institution - 405, Swansea, SA2 8QA, United Kingdom|Singleton Hospital, Swansea, SA2 8QA, United Kingdom|Local Institution - 482, Wolverhampton, WV10 OPQ, United Kingdom|New Cross Hospital, Wolverhampton, WV10 OPQ, United Kingdom|Local Institution - 436, Worcester, WR5 1DD, United Kingdom|Worcestershire Acute Hospitals NHS Trust, Worcester, WR5 1DD, United Kingdom","Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/28/NCT01734928/Prot_SAP_000.pdf"
